Skip to main content

Table 2 Associations between LY6D expression and clinicopathological characteristics in Cohort III

From: Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer

LY6D expression

TURB

Cystectomy

0

1

2

P-value

0

1

2

P-value

n(%)

74 (51.4)

42 (29.2)

28 (19.4)

 

56 (55.4)

32 (31.7)

13 (12.9)

 

Age

 Mean, median

67.8, 69.7

69.6, 70.6

69.6, 72.5

0.421

69.7, 72.6

70.3, 70.6

74.0, 74.3

0.288

 range

38.7–83.3

45.6–90.0

48.0–81.7

 

38.7–82.7

50.3–81.7

57.6–83.3

 

Sex

 Male

57 (77)

37 (88.1)

20 (71.4)

0.878

44 (78.6)

26 (81.3)

9 (69.2)

0.644

 Female

17 (23)

5 (11.9)

8 (28.6)

 

12 (21.4)

6 (18.8)

4 (30.8)

 

Preoperative T-stage

 T2

44 (59.5)

20 (47.6)

12 (42.9)

0.018

26 (46.4)

16 (50.0)

7 (53.8)

0.677

 T3

26 (35.1)

14 (33.3)

10 (35.7)

 

21 (37.5)

14 (43.8)

4 (30.8)

 

 T4

4 (5.4)

8 (19.0)

6 (21.4)

 

9 (16.1)

2 (6.3)

2 (15.4)

 

Postoperative T-stage

 pT0/pTa/CIS only

26 (35.1)

14 (33.3)

4 (14.3)

0.093

7 (12.5)a

5 (15.6)

2 (15.4)

0.349

 pT1

7 (9.5)

4 (9.5)

2 (7.1)

 

6 (10.7)

4 (12.5)

1 (7.7)

 

 pT2

14 (18.9)

8 (19.0)

7 (25.0)

 

11 (19.6)

6 (18.8)

3 (23.1)

 

 pT3

19 (25.7)

10 (23.8)

13 (46.4)

 

20 (35.7)

14 (43.8)

7 (53.8)

 

 pT4

8 (10.8)

6 (14.3)

2 (7.1)

 

12 (21.4)

3 (9.4)

0 (0.0)

 

N-stage

 N0

51 (68.9)

31 (73.8)

20 (71.4)

0.818

31 (55.4)

23 (71.9)

11 (84.6)

0.017

 N1

8 (10.8)

5 (11.9)

3 (10.7)

 

7 (12.5)

3 (9.4)

2 (15.4)

 

 N2

8 (10.8)

4 (9.5)

1 (3.6)

 

10 (17.9)

2 (6.3)

0 (0.0)

 

 N3

7 (9.5)

2 (4.8)

4 (14.3)

 

8 (14.3)

4 (12.5)

0 (0.0)

 

LVI in cystectomy

 No

46 (93.9)

26 (89.7)

23 (100.0)

0.448

44 (89.8)

26 (92.9)

12 (100.0)

0.253

 Yes

3 (6.1)

3 (10.3)

0 (0.0)

 

5 (10.2)

2 (7.1)

0 (0.0)

 

Missing

25

13

5

 

7

4

1

 

CIS in TURB specimens

 Not found

69 (93.2)

34 (81.0)

26 (92.9)

0.532

49 (87.5)

28 (87.5)

13 (100.0)

0.299

 Found

5 (6.8)

8 (19.0)

2 (7.1)

 

7 (12.5)

4 (12.5)

0 (0.0)

 

CIS in cystectomy specimens

 Not found

60 (81.1)

34 (81.0)

25 (89.3)

0.396

40 (71.4)

25 (78.1)

13 (100.0)

0.039

 Found

14 (18.9)

8 (19.0)

3 (10.7)

 

16 (28.6)

7 (21.9)

0 (0.0)

 

NAC

 No

39 (52.7)

21 (50.0)

19 (67.9)

0.262

40 (71.4)

22 (68.8)

10 (76.9)

0.840

 Yes

35 (47.3)

21 (50.0)

9 (32.1)

 

16 (28.6)

10 (31.3)

3 (23.1)

 
  1. aCystectomy specimens with tumour stage pT0 were excluded from the analysis
  2. Correlations with grade were not analyzed since all 145 TURB tumours were high-grade and
  3. only 3/104 assessable cystectomy tumours were low-grade
  4. Correlations with M-stage were not analyzed since only 3 cases were M1
  5. CIS Carcinoma in situ, NAC neoadjuvant chemotherapy
  6. 0 = Negative LY6D expression, 1 = ≤ 50% positive LY6D expression, 2 = > 50% LY6D expression
  7. P-value < 0.05 is considered significant